Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-934-9 | CAS number: 6846-50-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Additional information
The acute oral toxicity of 1-isopropyl-2,2-dimethyltrimethylene diisobutyrate is well understood. In an acute oral toxicity limit study conducted according to EPA OPPTS 870.1100 and OECD 425 guidelines, 1-isopropyl-2,2-dimethyltrimethylene diisobutyrate had an acute oral LD50 value of >2000 mg/kg bw in female rats. There were no significant clinical signs, body weight changes or gross pathological observations to indicate systemic toxicity. Two lesser non-guideline studies in rats and mice support the oral LD50 value. In these studies, no deaths were observed in rats receiving 3200 mg/kg bw while a single death was recorded in mice administered doses up to 6400 mg/kg bw. The death in the single mouse did not occur in the high-dose group. While moderate weakness and some vasodilatation occurred following dosing in the older non-guideline rat study, no clinical signs were observed in mice or the more recent rat study.
Acute Dermal Toxicity
The acute dermal toxicity of 1-isopropyl-2,2-dimethyltrimethylene diisobutyrate is well understood. In an acute dermal toxicity study conducted according to OECD Guideline 402, 1-isopropyl-2,2-dimethyltrimethylene diisobutyrate had an acute dermal LD50 value of >2000 mg/kg bw in male and female rabbits. There were no significant clinical signs, body weight changes or gross pathological observations to indicate systemic toxicity. In a non-guideline study in which three guinea pigs were exposed to 5, 10 or 20 mL/kg bw of the undiluted test material on shaved intact skin under occlusive wrap for 24-hours, no animals died. No clinical signs indicating systemic toxicity were reported and while animals receiving the low- and mid-doses lost weight during the study, the animal receiving the highest dose gained weight.
Acute Inhalation Toxicity
The acute inhalation toxicity of 1-isopropyl-2,2-dimethyltrimethylene diisobutyrate is well understood. Although a study has not been conducted according to OECD Guideline 403, a non-guideline study conducted in rats was available for review. No deaths, significant clinical signs, or adverse effects on body weight gain were observed in groups of three rats exposed to 0.12 mg/L (10 ppm) or 5.3 mg/L (453 ppm) of the test substance for 6 hours followed by a 2-week observation period. The latter exposure level could only be generated by heating the test material to 100 °C in a washing bottle before it was passed into the chamber containing the rats. 1-isopropyl-2,2-dimethyltrimethylene diisobutyrate is a liquid at room temperature, has a boiling point of 281.5°C, and has an extremely low vapor pressure (0.00088 mbar) at room temperature. Based on the physical properties of 1-isopropyl-2,2 -dimethyltrimethylene diisobutyrate, the potential for significant inhalation exposure is limited.
Justification for classification or non-classification
Based on a weight-of-the-evidence assessment 1 -isopropyl-2,2 -dimethyltrimethylene diisobutyrate is not classified for lethality by the oral, dermal, or inhalation routes according to EU CLP. Based on a weight-of-the-evidence assessment, 1 -isopropyl-2,2 -dimethyltrimethylene diisobutyrate is also not classified for “Specific Target Organ Effects – Single Exposure” according to GHS. No significant clinical signs, body weight changes or gross pathological observations to indicate systemic toxicity were observed by any route of exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)